tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PremiumCompany AnnouncementsXORTX Extends Deadline for Vectus Renal Anti-Fibrotic Program Acquisition and Sets March Shareholder Meeting
1M ago
Premium
Company Announcements
XORTX Highlights New Gout Genetics Research, Reshapes Board and Clarifies Financing as Vectus Deal Nears Closing
2M ago
XORTX Leans Into Genetic Breakthroughs in Gout as It Reshapes Board and Advances Oxypurinol
Premium
Company Announcements
XORTX Leans Into Genetic Breakthroughs in Gout as It Reshapes Board and Advances Oxypurinol
2M ago
XORTX Receives Nasdaq Notification for Bid Price Deficiency
PremiumCompany AnnouncementsXORTX Receives Nasdaq Notification for Bid Price Deficiency
5M ago
XORTX Therapeutics Announces US$1.1 Million Direct Offering
Premium
Company Announcements
XORTX Therapeutics Announces US$1.1 Million Direct Offering
5M ago
Xortx Therapeutics prices 1.75M shares at 63c in registered direct offering
Premium
The Fly
Xortx Therapeutics prices 1.75M shares at 63c in registered direct offering
5M ago
Xortx to acquire Renal Anti-Fibrotic Therapeutic Program from Vectus for $3M
PremiumThe FlyXortx to acquire Renal Anti-Fibrotic Therapeutic Program from Vectus for $3M
5M ago
Xortx Therapeutics files to sell 4.76M common shares
Premium
The Fly
Xortx Therapeutics files to sell 4.76M common shares
6M ago
XORTX Therapeutics to Host Investor Webinar on Strategic Developments
Premium
Company Announcements
XORTX Therapeutics to Host Investor Webinar on Strategic Developments
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100